Breakdown | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
---|---|---|---|---|---|
Income Statement | |||||
Total Revenue | 5.92T | 5.75T | 5.67T | 5.45T | 5.31T |
Gross Profit | 2.51T | 2.43T | 2.41T | 2.46T | 2.38T |
EBITDA | 1.82T | 1.62T | 1.71T | 1.78T | 1.76T |
Net Income | 685.68B | 637.87B | 679.11B | 672.49B | 651.50B |
Balance Sheet | |||||
Total Assets | 16.88T | 14.15T | 11.92T | 11.08T | 10.54T |
Cash, Cash Equivalents and Short-Term Investments | 1.36T | 887.21B | 844.97B | 1.12T | 1.11T |
Total Debt | 4.44T | 2.43T | 1.65T | 1.74T | 1.76T |
Total Liabilities | 11.23T | 8.35T | 6.25T | 5.57T | 5.28T |
Stockholders Equity | 5.13T | 5.25T | 5.12T | 4.98T | 4.76T |
Cash Flow | |||||
Free Cash Flow | 566.11B | 956.97B | 444.74B | 793.08B | 1.06T |
Operating Cash Flow | 1.25T | 1.71T | 1.08T | 1.47T | 1.68T |
Investing Cash Flow | -1.18T | -832.43B | -732.48B | -761.59B | -658.92B |
Financing Cash Flow | -33.55B | -476.48B | -669.84B | -727.26B | -585.57B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
80 Outperform | $18.14B | 12.55 | 17.71% | 7.11% | -5.13% | -5.90% | |
76 Outperform | $64.21B | 20.20 | 13.28% | 0.93% | 2.22% | 64.92% | |
74 Outperform | $55.32B | 19.23 | 14.41% | 2.75% | -0.64% | 56.92% | |
67 Neutral | $34.43B | 29.40 | 9.59% | 3.70% | 3.12% | 3.06% | |
64 Neutral | £1.86B | 9.43 | -20.06% | 3.64% | 2.24% | -54.62% | |
62 Neutral | $27.83B | 9.21 | -7.17% | 4.40% | 0.89% | -494.16% | |
60 Neutral | $30.12B | ― | -3.55% | 6.65% | -2.29% | -182.68% |